Brayoptus Pharma Private Limited
About Brayoptus Pharma Private Limited
Data last updated:
Brayoptus Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2014PTC151531. Its GSTIN is 27AAFCB9947D1ZG (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Swapnil Shankarrao Jadhav and Karbhari Kundlik Mithe.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No – 13/7 Pawar Nagar Thergaon, Pune, Maharashtra, India – 411033.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.05 Cr, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹25.38 Lakh (net margin 5%) and EBITDA of ₹41.73 Lakh (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 62% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSurvey No – 13/7 Pawar Nagar Thergaon, Pune, Maharashtra, India – 411033
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Brayoptus Pharma Private Limited
The main business activity of Brayoptus Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Brayoptus Pharma Private Limited FY 2025 filings available
Brayoptus Pharma Private Limited reported revenue of ₹5.05 Cr (up 66% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Brayoptus Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 62% over five years, including 66% growth in the latest year. EBITDA rose 136% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Brayoptus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹41.73 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25.38 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Brayoptus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Brayoptus Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Brayoptus Pharma Private Limited
Brayoptus Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Young Mind Exim Private Limited | ₹5.08 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Kolkata, West Bengal, India |
| Janarogyam Generic Private Limited | ₹5.07 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Rahata, Maharashtra, India |
| Sanitex Chemicals Limited | ₹5.07 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Sarangpur, Gujarat, India |
| Maxxsun Pharmaceuticals Private Limited | ₹5.07 Cr (FY 2025) | •••• | •••• | •••• | Kalyan, Maharashtra, India | |
| Diamond Lifesciences Private Limited | ₹5.05 Cr (FY 2024) | •••• | •••• | 50.0% | •••• | Mumbai, Maharashtra, India |
| Brayoptus Pharma Private Limited this company | ₹5.05 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Pune, Maharashtra, India |
| Medisam Biomedical Systems Private Limited | ₹5.05 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Sangli, Maharashtra, India |
| Keyur Pharmachem India Private Limited | ₹5.05 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Thane, Maharashtra, India |
| Arrow Pharmaceuticals Private Limited | ₹5.04 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Patna, Bihar, India |
| Mediserve Wellness Private Limited | ₹5.04 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Pune, Maharashtra, India |
| Good Deal Corporate Solutions Private Limited | ₹5.03 Cr (FY 2024) | •••• | •••• | 42.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Brayoptus Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Brayoptus Pharma Private Limited
Brayoptus Pharma Private Limited is audited by A. I. Jain & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A. I. Jain & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Brayoptus Pharma Private Limited
Brayoptus Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Shankarrao Jadhav Also directs: MJ Lifescience LLP, Organto Natural Food Products LLP | Director | 23 Jun 2014 | 12 Years 3 Months | Current |
| Karbhari Kundlik Mithe Also directs: MJ Lifescience LLP, Organto Natural Food Products LLP | Director | 23 Jun 2014 | 12 Years 3 Months | Current |
Ownership and Shareholding of Brayoptus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Brayoptus Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2024 | Hdfc Bank Limited | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Brayoptus Pharma Private Limited
Brayoptus Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Brayoptus Pharma Private Limited
Employment history and EPFO contributions of people linked to Brayoptus Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Brayoptus Pharma Private Limited
Brayoptus Pharma Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Karbhari Kundlik Mithe was appointed as Director on 23 Jun 2014.
Credit Ratings, Litigation & Regulatory Alerts for Brayoptus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Brayoptus Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Brayoptus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Brayoptus Pharma Private Limited
Brayoptus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCB9947D1ZG | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Brayoptus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brayoptus Pharma Private Limited
Brayoptus Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 June 2014 (12+ years old) and is registered under CIN U51909PN2014PTC151531.
Brayoptus Pharma reported revenue of ₹5.05 Cr for FY 2025 (up 66% YoY).
Brayoptus Pharma has 2 current directors:
- Swapnil Shankarrao Jadhav - Director
- Karbhari Kundlik Mithe - Director
Brayoptus Pharma reported a net profit of ₹25.38 Lakh (net margin 5%) and EBITDA of ₹41.73 Lakh (EBITDA margin 8.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Brayoptus Pharma is 32% over three years and 62% over five years. In the latest year (FY 2025) revenue rose 66%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Brayoptus Pharma is 27AAFCB9947D1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Brayoptus Pharma is U51909PN2014PTC151531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brayoptus Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Brayoptus Pharma was incorporated on 23 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Brayoptus Pharma by revenue are Young Mind Exim Private Limited, Janarogyam Generic Private Limited, Sanitex Chemicals Limited, Maxxsun Pharmaceuticals Private Limited, Diamond Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Karbhari Kundlik Mithe was appointed as Director on 23 Jun 2014. Swapnil Shankarrao Jadhav was appointed as Director on 23 Jun 2014.